Vaccines & Immunity Archives - Page 2 of 19

Summary:
As of April 8, 2020, CEPI reports 115 vaccine candidates are in varying stages of development, 78 of which are confirmed as active and 37 are unconfirmed. To end the COVID-19 Pandemic safe and effective vaccines will be required for the entire global population. Estimated requirement: 5 billion doses.
Published for educational purposes and social benefit, not for profit. Not a recommendation or endorsement. Always consult your doctor for medical advice.

September 2020

ACS | REVIEW | Peptide-Based Vaccines: Current Progress and Future Challenges

Peter2020-09-05T11:29:27+00:00September 5th, 2020|

In this Review, we discuss peptide-based vaccines and their potential in three therapeutic areas: infectious disease, Alzheimer’s disease, and cancer. Abstract Vaccines have had a profound impact on the management [...]

Reference: Virus-like particles (VLPs) for vaccine development

Peter2020-09-07T10:39:46+00:00September 5th, 2020|

Virus-like particle (VLP) is a self-assembled nanostructure incorporating key viral structural proteins. VLP resembles molecular and morphological features of authentic viruses but is non-infectious and non-replicating due to lack of [...]

WHO Draft landscape of COVID-19 candidate vaccines – 3 Sept 2020

Peter2020-09-07T12:14:24+00:00September 3rd, 2020|

WHO Draft landscape of COVID-19 candidate vaccines (181): 61 Protein Subunit Vaccines 43 vector vaccines 24 RNA vaccines 16 DNA vaccines 14 VLP vaccines Download Report Learn More: Evolution of [...]

NIAID NIH GOV | VACCINE TYPES | Whole-Pathogen Vaccines | Subunit Vaccine | Nucleic Acid Vaccines

Peter2020-09-03T06:23:12+00:00September 3rd, 2020|

Vaccine Types Scientific research has led to the development of numerous types of vaccines that safely elicit immune responses that protect against infection, and researchers continue to investigate novel vaccine [...]

NATURE | Correspondence | Implications of antibody-dependent enhancement [ADE] of infection for SARS-CoV-2 countermeasures

Peter2020-09-03T06:32:31+00:00September 3rd, 2020|

Published: 05 June 2020 Nikolai Eroshenko, Taylor Gill, Marianna K. Keaveney, George M. Church, Jose M. Trevejo & Hannu Rajaniemi Source: Nature Biotechnology volume 38, pages789–791(2020) https://doi.org/10.1038/s41587-020-0577-1 Download PDF Reprinted [...]

RADVAC | Rapid Deployment Vaccine Collaborative | Open Covid Pledge

Peter2020-09-03T06:07:40+00:00September 1st, 2020|

DOWNLOAD THE WHITE PAPER RADVAC MISSION The SARS-CoV-2 pandemic has become the greatest global public health crisis in a century. Experts say a vaccine is our best hope for ending [...]

August 2020

UNIVERSITY OF CAMBRIDGE | NEWS RELEASE | Cambridge-developed SARS-CoV-2 vaccine receives £1.9million from UK government for clinical trial

Peter2020-08-29T03:20:12+00:00August 29th, 2020|

A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9million award from the UK government. Source: [...]

NATURE | NEWS EXPLAINER | The unequal scramble for coronavirus vaccines — by the numbers Wealthy countries have already pre-ordered more than two billion doses.

Peter2020-08-29T02:29:43+00:00August 29th, 2020|

Wealthy countries have struck deals to buy more than two billion doses of coronavirus vaccine in a scramble that could leave limited supplies in the coming year. Meanwhile, an international [...]

CELL | Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

Peter2020-08-20T00:11:06+00:00August 20th, 2020|

Highlights 1. Acute phase SARS-CoV-2-specific T cells display an activated cytotoxic phenotype 2. Broad and polyfunctional SARS-CoV-2-specific T cell responses in convalescent phase 3. Detection of SARS-CoV-2-specific T cell responses [...]

PEPTIDE SYNTHESIS | Thermo Scientific | Custom Peptide Synthesis Services

Peter2020-09-05T15:29:57+00:00August 15th, 2020|

Thermo Scientific Custom Peptide synthesis service offers numerous options for synthesis platforms, purity levels, modifications, and formats to meet a variety of research needs. We synthesize peptides of 2–110 amino [...]